We have not looked at the charts of Pfizer (PFE) since October 26 when we wrote that "Ahead of Pfizer's earnings Tuesday the charts suggest that investors are not positioned for an upside move." We also noted that "In this daily Point and Figure chart of PFE we can see a potential upside price target around $42 but also that a decline to $36.74 will start to weaken the picture."
More from Investing
When you put them together, trading success is nearly inevitable.
You can't call this market overbought when so much of it isn't participating.
SKLZ shows explosion moves to the upside when it emerges from the oversold area.